158 related articles for article (PubMed ID: 10225735)
1. Immunoadsorption for the treatment of bullous pemphigoid.
Ino N; Kamata N; Matsuura C; Shinkai H; Odaka M
Ther Apher; 1997 Nov; 1(4):372-6. PubMed ID: 10225735
[TBL] [Abstract][Full Text] [Related]
2. A case of bullous pemphigoid successfully treated by plasmapheresis: assessment of the change in titers of circulating antibodies by immunoblotting and enzyme-linked immunosorbent assay.
Lee JB; Fumimori T; Kurose K; Mori O; Hashimoto T
J Dermatol; 2003 Apr; 30(4):326-31. PubMed ID: 12707470
[TBL] [Abstract][Full Text] [Related]
3. Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.
Herrero-González JE; Sitaru C; Klinker E; Bröcker EB; Zillikens D
Clin Exp Dermatol; 2005 Sep; 30(5):519-22. PubMed ID: 16045683
[TBL] [Abstract][Full Text] [Related]
4. Antibasement membrane zone antibodies in localized pretibial pemphigoid.
Muramatsu T; Iida T; Shirai T
Int J Dermatol; 1991 Jun; 30(6):422-4. PubMed ID: 1894407
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid.
Yamada H; Yaguchi H; Takamori K; Ogawa H
Ther Apher; 1997 May; 1(2):178-82. PubMed ID: 10225767
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis as a steroid saving procedure in bullous pemphigoid.
Egan CA; Meadows KP; Zone JJ
Int J Dermatol; 2000 Mar; 39(3):230-5. PubMed ID: 10759969
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic use of plasmapheresis in a patient with bullous pemphigoid].
Bandemir W; Krëger E
Vestn Dermatol Venerol; 1989; (2):10-3. PubMed ID: 2658406
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
9. Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report.
Kitabata Y; Sakurane M; Orita H; Kamimura M; Siizaki K; Narukawa N; Kaketaka A; Abe T; Kobata H; Akizawa T
Ther Apher; 2001 Dec; 5(6):484-90. PubMed ID: 11800086
[TBL] [Abstract][Full Text] [Related]
10. Pemphigoid nodularis (non-bullous): a clinicopathological study of five cases.
Powell AM; Albert S; Gratian MJ; Bittencourt R; Bhogal BS; Black MM
Br J Dermatol; 2002 Aug; 147(2):343-9. PubMed ID: 12174109
[TBL] [Abstract][Full Text] [Related]
11. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid.
Ahmadpoor P; Beck M; Michel M; Pambrun E; Stoebner P; Moranne O
J Clin Apher; 2024 Jun; 39(3):e22133. PubMed ID: 38881050
[TBL] [Abstract][Full Text] [Related]
12. Plasmapheresis therapy for bullous pemphigoid.
Goldberg NS; Robinson JK; Roenigk HH; Marder R; Rothe M
Arch Dermatol; 1985 Dec; 121(12):1484-5. PubMed ID: 3904634
[No Abstract] [Full Text] [Related]
13. [Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies].
Gary A; Carvalho P; Louison JB; Helot MF; Gilbert D; Bernard P; Roujeau JC; Bedane C; Delaporte E; Vaillant L; Dreno B; Saiag P; Tancrede-Bohin E; Plantin P; D'Incan M; Sassolas B; Lok C; Labeille B; Pauwels C; Chosidow O; Picard C; Loche F; Guillaume JC; Joly P
Ann Dermatol Venereol; 2004 Apr; 131(4):333-7. PubMed ID: 15258506
[TBL] [Abstract][Full Text] [Related]
14. [Immunopathological studies of the skin of patients with pemphigoid at different stages of the disease].
Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
Przegl Dermatol; 1990; 77(5):318-22. PubMed ID: 2270294
[TBL] [Abstract][Full Text] [Related]
15. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies.
Asbrink E; Hovmark A
Acta Derm Venereol; 1984; 64(3):243-6. PubMed ID: 6204487
[TBL] [Abstract][Full Text] [Related]
16. A case of severe bullous pemphigoid treated with plasmapheresis.
Lee MW; Lee WS; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatolog Treat; 2001 Mar; 12(1):59-60. PubMed ID: 12171691
[No Abstract] [Full Text] [Related]
17. [A severe course of bullous pemphigoid in a young man].
Eigelshoven S; Bruch-Gerharz D; Enderlein E; Ruzicka T; Büchau AS; Hertl M; Reifenberger J; Schulte KW
Hautarzt; 2006 Apr; 57(4):320-2. PubMed ID: 16523275
[No Abstract] [Full Text] [Related]
18. Bullous Pemphigoid Successfully Treated With a Combination Therapy of Plasmapheresis Followed by Intravenous High Dose Immunoglobulin.
Hattori Y; Takahashi T; Seishima M
Ther Apher Dial; 2017 Aug; 21(4):421-423. PubMed ID: 28378368
[No Abstract] [Full Text] [Related]
19. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
Briggaman RA; Gammon WR; Woodley DT
J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
[TBL] [Abstract][Full Text] [Related]
20. Use of sodium-chloride separated human skin in detection of circulating anti-basement membrane zone antibodies.
Rasmussen HB; Brandrup F; Andersen J; Hagdrup H
Acta Derm Venereol; 1989; 69(6):515-9. PubMed ID: 2575326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
